Purification and characterization of 3 fibrinogens with different molecular weights obtained from normal human plasma. 1985

B Holm, and D W Nilsen, and P Kierulf, and H C Godal

Fibrinogen was purified from fresh citrated human plasma by precipitation with beta-alanine in the presence of citrate and protease inhibitors. From this material, fractions corresponding to the HMW (high molecular weight), LMW and LMW' fibrinogen fractions of plasma were obtained by step-wise precipitation with ammonium sulfate. Electrophoresis revealed that HMW was contaminated with 4% LMW, LMW was contaminated with 6% HMW, and the LMW'-fraction was a mixture of LMW' (50%), LMW (20%) and two derivatives of intermediate m.w.. The HMW fraction (mw. 340 000) contained intact Aa-chains, while the molecular weight of LMW was reduced to 305 000 and that of LMW' to 270 000 due to proteolysis of the -COOH terminal end of one (LMW) or both (LMW') Aa-chains. The clottability of HMW was 98%, of LMW 92% and of LMW' about 80%. Thrombin clotting times (1 NIH U/ml) were 14", 20" and 25" resp. These differences were highly accentuated when clotting was performed with reptilase (14", 38" and 120"). Contamination with soluble fibrin was less than 2% and the contents of fibronectin and AT-III were low. No thrombin or plasmin activity was generated upon 24 hours incubation at +4 degrees C as evidenced by increased content of fibrinopeptide-A and fragment Bb-15-42 resp.

UI MeSH Term Description Entries
D008970 Molecular Weight The sum of the weight of all the atoms in a molecule. Molecular Weights,Weight, Molecular,Weights, Molecular
D004591 Electrophoresis, Polyacrylamide Gel Electrophoresis in which a polyacrylamide gel is used as the diffusion medium. Polyacrylamide Gel Electrophoresis,SDS-PAGE,Sodium Dodecyl Sulfate-PAGE,Gel Electrophoresis, Polyacrylamide,SDS PAGE,Sodium Dodecyl Sulfate PAGE,Sodium Dodecyl Sulfate-PAGEs
D005340 Fibrinogen Plasma glycoprotein clotted by thrombin, composed of a dimer of three non-identical pairs of polypeptide chains (alpha, beta, gamma) held together by disulfide bonds. Fibrinogen clotting is a sol-gel change involving complex molecular arrangements: whereas fibrinogen is cleaved by thrombin to form polypeptides A and B, the proteolytic action of other enzymes yields different fibrinogen degradation products. Coagulation Factor I,Factor I,Blood Coagulation Factor I,gamma-Fibrinogen,Factor I, Coagulation,gamma Fibrinogen
D006801 Humans Members of the species Homo sapiens. Homo sapiens,Man (Taxonomy),Human,Man, Modern,Modern Man

Related Publications

B Holm, and D W Nilsen, and P Kierulf, and H C Godal
March 1984, Biochimica et biophysica acta,
B Holm, and D W Nilsen, and P Kierulf, and H C Godal
September 1987, Thrombosis research,
B Holm, and D W Nilsen, and P Kierulf, and H C Godal
January 1985, Scandinavian journal of clinical and laboratory investigation. Supplementum,
B Holm, and D W Nilsen, and P Kierulf, and H C Godal
January 1985, Journal of clinical & laboratory immunology,
B Holm, and D W Nilsen, and P Kierulf, and H C Godal
January 1983, The Journal of clinical endocrinology and metabolism,
B Holm, and D W Nilsen, and P Kierulf, and H C Godal
December 1971, The Biochemical journal,
B Holm, and D W Nilsen, and P Kierulf, and H C Godal
January 1981, Hypertension (Dallas, Tex. : 1979),
B Holm, and D W Nilsen, and P Kierulf, and H C Godal
January 1975, Acta biologica et medica Germanica,
B Holm, and D W Nilsen, and P Kierulf, and H C Godal
January 2020, Frontiers in pharmacology,
B Holm, and D W Nilsen, and P Kierulf, and H C Godal
January 2017, Mikrobiyoloji bulteni,
Copied contents to your clipboard!